Image

Rezum for 30-80ml Patients With Moderate-severe LUTS to Study Surgical Principles for Median Lobe Enlargement

Recruiting
50 - 85 years of age
Male
Phase N/A

Powered by AI

Overview

This study was created to determine the safety and efficacy of treating prostatic hyperplasia with or without prominent median lobe enlargement with the REZUM technique. The systematic implementation of decisions for the location, vapor time, and the number of injections contributes to the Rezum procedure configuration for the median lobe treatment being safer and standardizer.

Eligibility

Inclusion Criteria:

  • Patients aged 50 to 85 years who have been diagnosed with benign prostatic hyperplasia at Seoul National University Hospital and are scheduled to undergo endoscopic surgery.
  • benign prostatic hyperplasia ≥ 30 and < 80 ml
  • Patients who have given written informed consent to participate in the study according to their age
  • A urinary symptom score (International ProstateSymptom Score [IPSS] moderated (8-19 points) to severe (20-35 points)
  • Measured Postvoiding Residual (PVR) <250 mL

Exclusion Criteria:

  • History of prostate or bladder cancer, neurogenic bladder, bladder calculus, or clinically significant bladder diverticulum
  • Active infection, treatment for chronic prostatitis
  • Diagnosis of urethral stricture, meatal stenosis or bladder neck contracture, damaged external urinary sphincter, stress urinary incontinence, post-void residual >300 mL or urinary retention, or prior prostate surgery
  • Men taking anticoagulants or on bladder anticholinergics or with severe cardiovascular disease
  • PSA greater than 4.0 ng/ml (unless prostate cancer was ruled out by biopsy)
  • Allergy to device materials, immune suppressants or corticosteroids use, and serious medical or mental illness.

Study details

Prostatic Hyperplasia of the Medial Lobe

NCT06177821

Seoul National University Hospital

29 April 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.